NeoChord
- Business Model
- B2B
- Website
- neochord.com
- Total Funding
- $40.9M
- Last Round
- $493K SeedMar 2025
- Rounds
- 4
About
Medical technology company advancing beating-heart mitral valve repair for patients with mitral regurgitation.
Summary
NeoChord is a Biotech company. It has raised $40.9M in total across 4 rounds, most recently a $493K Seed round in Mar 2025. Investors include Deerfield Management, US Venture Partners and Treo Ventures.
Tech & App Stack
7 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Mar 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...